About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Casp8
caspase 8
MGI:1261423
62 phenotypes from multigenic genotypes
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Casp8em1Hbz/Casp8em1Hbz
Mlklem1Hbz/Mlklem1Hbz
involves: C57BL/6
decreased B cell number J:342732
decreased leukocyte cell number J:342732
decreased lymphocyte cell number J:342732
decreased mature B cell number J:342732
decreased T cell number J:342732
enlarged spleen J:342732
increased CD11b-high dendritic cell number J:342732
increased granulocyte number J:342732
increased macrophage cell number J:342732
Casp8em1Hbz/Casp8em1Hbz
Ripk1em1Hbz/Ripk1em1Hbz
Ripk3tm1Xidw/Ripk3tm1Xidw
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
decreased leukocyte cell number J:342732
decreased lymphocyte cell number J:342732
decreased mature B cell number J:342732
decreased T cell number J:342732
Casp8em1Hbz/Casp8em1Hbz
Ripk1em4Hbz/Ripk1em4Hbz
Ripk3tm1Xidw/Ripk3tm1Xidw
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
decreased body size J:342732
preweaning lethality, complete penetrance J:342732
scaly skin J:342732
skin lesions J:342732
Casp8em1Hbz/Casp8em1Hbz
Ripk3tm1Xidw/Ripk3tm1Xidw
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
decreased B cell number J:342732
decreased leukocyte cell number J:342732
decreased lymphocyte cell number J:342732
decreased mature B cell number J:342732
decreased T cell number J:342732
enlarged spleen J:342732
increased CD11b-high dendritic cell number J:342732
increased granulocyte number J:342732
increased macrophage cell number J:342732
Casp8tm1.1Raz/Casp8tm1.1Raz
Otulinem1Gvl/Otulinem1Gvl
Ripk3tm1Vmd/Ripk3tm1Vmd
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J
normal embryo phenotype J:312394
enlarged lymph nodes J:312394
normal immune system phenotype J:312394
normal integument phenotype J:312394
Casp8tm1.1Raz/Casp8tm1.1Raz
Ripk3tm1Vmd/Ripk3+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
abnormal visceral yolk sac blood island morphology J:170815
abnormal vitelline vasculature morphology J:170815
embryonic growth arrest J:170815
embryonic lethality, complete penetrance J:170815
Casp8tm1.1Raz/Casp8tm1.1Raz
Ripk3tm1Vmd/Ripk3tm1Vmd
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
abnormal liver physiology J:170815
abnormal macrophage physiology J:170815
decreased hepatocyte apoptosis J:170814
decreased macrophage apoptosis J:170815
decreased thymocyte apoptosis J:170814
enlarged axillary lymph nodes J:170815
enlarged cervical lymph nodes J:170815
enlarged lymph nodes J:170814
enlarged spleen J:170814, J:170815
enlarged thymus J:170814
normal growth/size/body region phenotype J:170814
normal hematopoietic system phenotype J:170814, J:170815
normal immune system phenotype J:170815
increased B cell number J:170815
increased inflammatory response J:170815
increased leukocyte cell number J:170815
increased spleen white pulp amount J:170815
increased T cell number J:170814, J:170815
large lymphoid organs J:170814
lymph node hyperplasia J:170815
normal mortality/aging J:170814, J:170815
Casp8tm1.1Vmd/Casp8+
Ripk3tm2Vmd/Ripk3tm2Vmd
involves: C57BL/6N
lethality throughout fetal growth and development, complete penetrance J:209137
Casp8tm1.1Vmd/Casp8tm1.1Vmd
Ripk3tm2Vmd/Ripk3tm2Vmd
involves: C57BL/6N
enlarged lymph nodes J:209137
enlarged spleen J:209137
increased T cell number J:209137
normal mortality/aging J:209137
Casp8tm1Clie/Casp8tm1Clie
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr
Tg(Alb1-cre)7Gsc/0
involves: 129P2/OlaHsd * C57BL/6 * FVB/N
abnormal biliary tract morphology J:218665
abnormal circulating enzyme level J:218665
abnormal liver morphology J:218665
decreased body size J:218665
enlarged liver J:218665
hepatic necrosis J:218665
increased bile salt level J:218665
increased circulating alkaline phosphatase level J:218665
increased circulating bilirubin level J:218665
intrahepatic cholestasis J:218665
liver fibrosis J:218665
normal neoplasm J:218665
Casp8tm1Clie/Casp8tm1Clie
Map3k7tm1Aki/Map3k7tm1Aki
Tg(Alb1-cre)7Gsc/0
involves: 129P2/OlaHsd * FVB/N
abnormal bile duct morphology J:160521
abnormal liver morphology J:160521
bile duct proliferation J:160521
focal hepatic necrosis J:160521
increased circulating alanine transaminase level J:160521
increased circulating aspartate transaminase level J:160521
increased circulating bilirubin level J:160521
normal mortality/aging J:160521
postnatal growth retardation J:160521
Casp8tm1Syon/Casp8tm1Syon
Tg(Myh7-BVp35-EGFP)#Ksa/?
involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6
abnormal neural tube morphology J:102279
abnormal vitelline vasculature morphology J:102279
normal cardiovascular system phenotype J:102279
embryonic lethality during organogenesis, complete penetrance J:102279
hemopericardium J:102279
increased cardiomyocyte apoptosis J:102279

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/19/2024
MGI 6.24
The Jackson Laboratory